The page is the record's research on the issuer — no analyst, no rating, no view. # Korro Bio, Inc. (NASDAQ: KRRO) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Korro Bio, Inc., listed on NASDAQ under ticker KRRO, with ISIN US5009461089. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 124 filings across 62 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 4 days. The latest filing is dated 2026-11-05, is a results filing, and falls 3 days before the record date of 2026-11-08, against an exchange median latency of 5.0 days and a sector median latency of 4.0 days. The exchange median cadence gap is 6.0 days, and the exchange median count of filings is 52. The sector median cadence gap is 6.0 days, and the sector median count of filings is 63.0. The filings by type are 49 directors' dealings, 51 regulatory filings, 9 corporate news, 8 results, 3 AGM or EGM, 3 prospectus, and 1 director change. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and its location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change events. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted. ## Orderability The outcome is not determinable, as the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001703647.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/KRRO (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/KRRO (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/KRRO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp